Confluent (NASDAQ:CFLT - Free Report) had its target price hoisted by Royal Bank of Canada from $33.00 to $36.00 in a research report released on Friday morning,Benzinga reports. They currently have an outperform rating on the stock.
A number of other research analysts have also commented on CFLT. Stifel Nicolaus upped their price target on Confluent from $34.00 to $37.00 and gave the company a "buy" rating in a research report on Wednesday, December 18th. Sanford C. Bernstein decreased their target price on Confluent from $38.00 to $33.00 and set an "outperform" rating for the company in a report on Friday, October 25th. Barclays raised their price target on Confluent from $32.00 to $35.00 and gave the stock an "overweight" rating in a research note on Friday, December 6th. Needham & Company LLC reissued a "buy" rating and set a $31.00 price objective on shares of Confluent in a research report on Friday, November 15th. Finally, DA Davidson reaffirmed a "buy" rating and issued a $30.00 target price on shares of Confluent in a research report on Wednesday, September 18th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $32.35.
View Our Latest Stock Report on CFLT
Confluent Trading Up 3.6 %
Shares of NASDAQ:CFLT traded up $1.01 during trading on Friday, reaching $29.26. 1,983,867 shares of the company traded hands, compared to its average volume of 2,406,634. The company has a current ratio of 4.24, a quick ratio of 4.24 and a debt-to-equity ratio of 1.17. Confluent has a 52-week low of $17.79 and a 52-week high of $35.07. The firm has a market capitalization of $9.60 billion, a price-to-earnings ratio of -26.36 and a beta of 0.91. The business's fifty day moving average is $29.15 and its 200-day moving average is $24.97.
Confluent (NASDAQ:CFLT - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported ($0.21) earnings per share for the quarter, beating the consensus estimate of ($0.24) by $0.03. Confluent had a negative net margin of 38.35% and a negative return on equity of 34.05%. The business had revenue of $250.20 million during the quarter, compared to analysts' expectations of $243.98 million. As a group, analysts forecast that Confluent will post -0.9 EPS for the current year.
Insider Activity at Confluent
In other news, CTO Chad Verbowski sold 13,414 shares of Confluent stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $28.23, for a total value of $378,677.22. Following the completion of the sale, the chief technology officer now directly owns 483,393 shares in the company, valued at $13,646,184.39. The trade was a 2.70 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO Kong Phan sold 2,096 shares of the business's stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $28.23, for a total transaction of $59,170.08. Following the transaction, the chief accounting officer now directly owns 190,680 shares of the company's stock, valued at $5,382,896.40. The trade was a 1.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 4,584,712 shares of company stock valued at $132,928,936 over the last 90 days. Corporate insiders own 13.82% of the company's stock.
Hedge Funds Weigh In On Confluent
A number of institutional investors and hedge funds have recently modified their holdings of the company. Diversified Trust Co lifted its holdings in Confluent by 110.3% in the third quarter. Diversified Trust Co now owns 60,503 shares of the company's stock valued at $1,233,000 after acquiring an additional 31,729 shares during the period. Sycomore Asset Management increased its position in shares of Confluent by 308.3% during the 2nd quarter. Sycomore Asset Management now owns 333,083 shares of the company's stock valued at $9,176,000 after purchasing an additional 251,507 shares during the last quarter. Quantbot Technologies LP lifted its stake in shares of Confluent by 1,465.6% in the 3rd quarter. Quantbot Technologies LP now owns 30,295 shares of the company's stock worth $617,000 after purchasing an additional 28,360 shares during the period. Pathway Capital Management LP purchased a new position in shares of Confluent in the third quarter worth approximately $918,000. Finally, Charles Schwab Investment Management Inc. grew its position in Confluent by 2.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,284,037 shares of the company's stock valued at $46,549,000 after buying an additional 64,926 shares during the period. 78.09% of the stock is currently owned by hedge funds and other institutional investors.
Confluent Company Profile
(
Get Free Report)
Confluent, Inc operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software.
Featured Articles
Before you consider Confluent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Confluent wasn't on the list.
While Confluent currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.